Phase I/II Trial of Combination of Temozolomide Chemotherapy and Immunotherapy With Fusions of Dendritic and Glioma Cells in Patients With Glioblastoma.
Publication/Presentation Date
7-1-2017
Volume
81
Issue
1
First Page
11
Last Page
11
ISSN
1524-4040
Published In/Presented At
Kim, W. J., Newman, W. C., & Amankulor, N. M. (2017). Phase I/II Trial of Combination of Temozolomide Chemotherapy and Immunotherapy With Fusions of Dendritic and Glioma Cells in Patients With Glioblastoma. Neurosurgery, 81(1), N11. https://doi.org/10.1093/neuros/nyx263
Disciplines
Medicine and Health Sciences
PubMedID
28873996
Department(s)
Department of Surgery
Document Type
Article
COinS